Amivantamab in the Treatment of Metastatic NSCLC: Patient Selection and Special Considerations
Iacopo Petrini,1 Giuseppe Giaccone2 1Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy; 2Weill-Cornell Medicine, Meyer Cancer Center, New York, NY, USACorrespondence: Giuseppe Giaccone, Weill-Cornell Medicine, Meyer C...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-10-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/amivantamab-in-the-treatment-of-metastatic-nsclc-patient-selection-and-peer-reviewed-fulltext-article-OTT |